您的位置: 首页 > 农业专利 > 详情页

BENZOTHIAZOLE AND AZABENZOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON ENDOTHELIAL LIPASE
专利权人:
SHIONOGI & CO.; LTD.
发明人:
YOSHIKAWA, NAOKI,吉川直树,吉川直樹,KIDA, SHIRO,木田士郎,木田士郎,YONEHARA, MITSUHIRO,米原光扩,米原光擴,NAKAJIMA, MADO,中嶋麻童,中嶋麻童
申请号:
TW100145931
公开号:
TW201305152A
申请日:
2011.12.13
申请国别(地区):
TW
年份:
2013
代理人:
摘要:
The present invention is related to the compounds of formula shown as following, pharmaceutically acceptable salts or solvates thereof.(wherein, X is =CR4- or =N- Y is =CR5- or =N- Z is =CR7- or =N- R4 and R7 each independently are hydrogen, halogen, cyano, substituted or non-substituted alkyl etc. when X is =CR4-, Y is =CR5-, and Z is =CR7-, R4 and R7 are not hydrogen simultaneously when X is =CR4-, Z is =CR7-, and R4 is halogen, R7 is not hydrogen R5 and R6 each independently are hydrogen, halogen, hydroxyl, cyano, nitro, carboxyl, substituted or non-substituted alkyl etc. R1 and R2 each independently are hydrogen, halogen, hydroxyl, cyano, nitro, carboxyl, substituted or non-substituted alkyl etc. R3 is a group shown as formula: -(CR8R9)m-R10 R8 independently is hydrogen, halogen, hydroxyl etc. R9 independently is hydrogen, halogen, hydroxyl etc. m is 0 to 3 R10 is carboxyl, substituted or non-substituted alkoxycarbonyl etc.).本發明為一種下式所示之化合物、其製藥上可接受之鹽或彼等之溶劑合物(式中,X為=CR4-或=N-;Y為-CR5=或-N=;Z為=CR7-或=N-;R4及R7為各自獨立之氫、鹵素、氰基、經取代或未經取代之烷基等;當X為=CR4-、Y為-CR5=、且Z為=CR7-時,R4及R7不同時為氫;當X為=CR4-、Z為=CR7-、且R4為鹵素時,R7不為氫;R5及R6為各自獨立之氫、鹵素、羥基、氰基、硝基、羧基、經取代或未經取代之烷基等;R1及R2為各自獨立之氫、鹵素、羥基、氰基、硝基、羧基、經取代或未經取代之烷基等;R3為式:-(CR8R9)m-R10所示之基;R8為各自獨立之氫、鹵素、羥基等;R9為各自獨立之氫、鹵素、羥基等;m為0~3之整数;R10為羧基、經取代或未經取代之烷氧羰基等)。
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充